Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization

被引:52
作者
Itzhak, Y
Martin, JL
Black, MD
Ali, SF
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol R62A, Miami, FL 33101 USA
[2] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Neurochem Lab, Jefferson, AR USA
关键词
methamphetamine; MPTP; melatonin; dopaminergic neurotoxicity; free radicals; locomotor activity; sensitization;
D O I
10.1016/S0028-3908(98)00067-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Methamphetamine (METH)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity is thought to be associated with the formation of free radicals. Since evidence suggests that melatonin may act as a free radical scavenger and antioxidant, the present study was undertaken to investigate the effect of melatonin on METH- and MPTP-induced neurotoxicity. In addition, the effect of melatonin on METH-induced locomotor sensitization was investigated. The administration of METH (5 mg kg(-1) x 3) or MPTP (20 mg kg(-1) x 3) to Swiss Webster mice resulted in 45-57% depletion in the content of striatal dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, and 57-59% depletion in dopamine transporter binding sites. The administration of melatonin (10 mg kg(-1)) before each of the three injections of the neurotoxic agents (on day 1), and thereafter for two additional days, afforded a full protection against METH-ieduced depletion of dopamine and its metabolites and dopamine transporter binding sites. In addition, melatonin significantly diminished METH-induced hyperthermia. However, the treatment with melatonin had no significant effect on MPTP-induced depletion of the dopaminergic markers tested. In the set of behavioral experiments, we found that the administration of 1 mg kg(-1) METH to Swiss Webster mice for 5 days resulted in marked locomotor sensitization to a subsequent challenge injection of METH, as well as context-dependent sensitization (conditioning). The pretreatment with melatonin (10 mg kg(-1)) prevented neither the sensitized response to METH nor the development of conditioned locomotion. Results of the present study indicate that melatonin has a differential effect on the dopaminergic neurotoxicity produced by METH and MPTP. Since it is postulated that METH-induced hyperthermia is related to its neurotoxic effect, while regulation of body temperature is unrelated to MPTP-induced neurotoxicity or METH-induced locomotor sensitization, the protective effect of melatonin observed in the present study may be due primarily to diminishing METH-induced hyperthermia. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 50 条
[21]   Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice [J].
Lorenzl, S ;
Calingasan, N ;
Yang, LC ;
Albers, DS ;
Shugama, S ;
Gregorio, J ;
Krell, HW ;
Chirichigno, J ;
Joh, T ;
Beal, MF .
NEUROMOLECULAR MEDICINE, 2004, 5 (02) :119-131
[22]   Neuroprotective Effect of Kaempferol against a 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease [J].
Li, Shen ;
Pu, Xiao-Ping .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) :1291-1296
[23]   Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions [J].
Lee, Jin-Moo ;
Hwang, Deok-Sang ;
Kim, Hyo Geun ;
Lee, Chang-Hoon ;
Oh, Myung Sook .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 139 (03) :883-888
[24]   Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice [J].
Navneet, A. K. ;
Appukuttan, T. A. ;
Pandey, M. ;
Mohanakumar, K. P. .
AMINO ACIDS, 2008, 35 (02) :457-461
[25]   Role of Lipoamide Dehydrogenase and Metallothionein on 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Neurotoxicity [J].
Muralikrishnan Dhanasekaran ;
Christian B. Albano ;
Lori Pellet ;
Senthilkumar S. Karuppagounder ;
Subramaniam Uthayathas ;
Vishnu Suppiramaniam ;
Holly Brown-Borg ;
Manuchair Ebadi .
Neurochemical Research, 2008, 33 :980-984
[26]   1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine [J].
Tabbal, S. D. ;
Mink, J. W. ;
Antenor, J. A. V. ;
Carl, J. L. ;
Moerlein, S. M. ;
Perlmutter, J. S. .
NEUROSCIENCE, 2006, 141 (03) :1281-1287
[27]   Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice [J].
Jian-Hui Liang ;
Keng Wang ;
Hong-Lei Sun ;
Rong Han .
Psychopharmacology, 2006, 185 :1-10
[28]   Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice [J].
Liang, JH ;
Wang, K ;
Sun, HL ;
Han, R .
PSYCHOPHARMACOLOGY, 2006, 185 (01) :1-10
[29]   1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lipid peroxidation and DNA damage in mouse bone marrow and blood [J].
Ortiz, GG ;
Zúñiga-González, G ;
García, JJ ;
Torres-Bugarín, O ;
Zamora-Perez, A ;
Bitzer-Quintero, OK .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2003, 41 (01) :64-68
[30]   Mechanism of Nanotization-Mediated Improvement in the Efficacy of Caffeine Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism [J].
Singhal, Naveen Kumar ;
Agarwal, Swati ;
Bhatnagar, Priyanka ;
Tiwari, Manindra Nath ;
Tiwari, Shashi Kant ;
Srivastava, Garima ;
Kumar, Pradeep ;
Seth, Brashket ;
Patel, Devendra Kumar ;
Chaturvedi, Rajnish Kumar ;
Singh, Mahendra Pratap ;
Gupta, Kailash Chand .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (12) :2211-2222